Ousheng Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ousheng Liu has a total of 177 co-authors. Here are the top co-authors by number of shared publications:
Fei Yan
Central South University
5 shared publicationsKaixin Su
Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South University, Changsha, Hunan, China; Hunan Key Laboratory of Oral Health Research & Hunan Clinical Research Center of Oral Major Diseases and Oral Health & Academician Workstation for Oral-maxilofacial and Regenerative Medicine, Central South University, Changsha, Hunan, China
5 shared publicationsZekun Zhou
Hunan Key Laboratory of Oral Health Research & Hunan Clinical Research Center of Oral Major Diseases and Oral Health & Academician Workstation for Oral-maxilofacial and Regenerative Medicine, Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South University, Changsha, China
5 shared publicationsJian Zhou
Salivary Gland Disease Center and Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Beijing Laboratory of Oral Health and Beijing Stomatological Hospital, Capital Medical University, Beijing, China; Department of VIP Dental Service, School of Stomatology, Capital Medical University, Beijing, China; Laboratory for Oral and General Health Integration and Translation, Beijing Tiantan Hospital, Capital Medical University, Beijing China
4 shared publicationsXiaohan Dai
Central South University
4 shared publicationsXinyan Cui
Hunan Key Laboratory of Oral Health Research & Hunan 3D Printing Engineering Research Center of Oral Care & Hunan Clinical Research Center of Oral Major Diseases and Oral Health & Academician Workstation for Oral-maxilofacial and Regenerative Medicine & Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South University, Changsha, China
4 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Springer Nature in International Journal of Oral Science
- Vol. 18 (1) , 70
Dual targeting of ACSS2 and ACLY by a novel inhibitor S8588 suppresses oncogenic lipogenesis and overcomes metabolic compensation in oral squamous cell carcinoma
Metabolic reprogramming, particularly enhanced lipid anabolism, is a hallmark of oral squamous cell carcinoma (OSCC), yet effective therapies targeting this process remain lacking. Here, we identify concurrent activation of acetyl-CoA synthetase 2 (ACSS2) and ATP-citrate lyase (ACLY) as a cooperative metabolic driver of OSCC progression. Whereas previous efforts have focused on single-enzyme inhibition, we show that ACSS2 and ACLY form a compensatory network that sustains lipid anabolism and drives OSCC progression, providing a rationale for their dual inhibition. Integrative transcriptomic and lipidomic analyses reveal a metabolically aggressive OSCC subset defined by concurrent ACSS2 and ACLY upregulation, which was associated with poor clinical outcomes. Dual inhibition of ACSS2 and ACLY depleted acetyl-CoA, suppressed lipogenesis, and impaired tumor growth in vitro and in vivo. We further identified S8588, a quinoxaline-based small molecule, as a dual-target degrader that induces ubiquitin–proteasome-dependent degradation of both ACSS2 and ACLY, thereby blocking OSCC proliferation. Mechanistically, S8588 directly binds key residues of both enzymes, promoting their proteasomal turnover. Supplementation with acetate and citrate reverses its anti-tumor effect, confirming acetyl-CoA depletion as the primary mechanism. Collectively, our findings establish ACSS2/ACLY co-activation as a therapeutic vulnerability in OSCC and nominate S8588 as a promising dual-target therapeutic to dismantle metabolic adaptability for improved treatment.
- 31 October 2026
- Published by Springer Nature in International Journal of Oral Science
- Vol. 18 (1) , 70
Open AccessDual targeting of ACSS2 and ACLY by a novel inhibitor S8588 suppresses oncogenic lipogenesis and overcomes metabolic compensation in oral squamous cell carcinoma
Metabolic reprogramming, particularly enhanced lipid anabolism, is a hallmark of oral squamous cell carcinoma (OSCC), yet effective therapies targeting this process remain lacking. Here, we identify concurrent activation of acetyl-CoA synthetase 2 (ACSS2) and ATP-citrate lyase (ACLY) as a cooperative metabolic driver of OSCC progression. Whereas previous efforts have focused on single-enzyme inhibition, we show that ACSS2 and ACLY form a compensatory network that sustains lipid anabolism and drives OSCC progression, providing a rationale for their dual inhibition. Integrative transcriptomic and lipidomic analyses reveal a metabolically aggressive OSCC subset defined by concurrent ACSS2 and ACLY upregulation, which was associated with poor clinical outcomes. Dual inhibition of ACSS2 and ACLY depleted acetyl-CoA, suppressed lipogenesis, and impaired tumor growth in vitro and in vivo. We further identified S8588, a quinoxaline-based small molecule, as a dual-target degrader that induces ubiquitin–proteasome-dependent degradation of both ACSS2 and ACLY, thereby blocking OSCC proliferation. Mechanistically, S8588 directly binds key residues of both enzymes, promoting their proteasomal turnover. Supplementation with acetate and citrate reverses its anti-tumor effect, confirming acetyl-CoA depletion as the primary mechanism. Collectively, our findings establish ACSS2/ACLY co-activation as a therapeutic vulnerability in OSCC and nominate S8588 as a promising dual-target therapeutic to dismantle metabolic adaptability for improved treatment.
- Open Access
- 27 June 2026
- Published by Elsevier in International Dental Journal
- Vol. 76 (5) , 109723
Decoding the Dynamic Landscape of Sequential Disease Stages from Oral Submucous Fibrosis to Oral Squamous Cell Carcinoma
- 27 June 2026
- Published by Elsevier in International Dental Journal
- Vol. 76 (5) , 109723
Open AccessDecoding the Dynamic Landscape of Sequential Disease Stages from Oral Submucous Fibrosis to Oral Squamous Cell Carcinoma
- Open Access
- 22 May 2026
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
Three-dimensional skeletal changes after miniscrew-assisted rapid palatal expansion in adults with maxillary transverse deficiency and mandibular deviation: a retrospective CBCT study
Miniscrew-assisted rapid palatal expansion has gained increasing use in skeletally mature patients with maxillary transverse deficiency. This study aimed t
- 22 May 2026
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
Open AccessThree-dimensional skeletal changes after miniscrew-assisted rapid palatal expansion in adults with maxillary transverse deficiency and mandibular deviation: a retrospective CBCT study
Miniscrew-assisted rapid palatal expansion has gained increasing use in skeletally mature patients with maxillary transverse deficiency. This study aimed t
- Open Access
- 13 January 2026
- Published by Springer Nature in International Journal of Oral Science
- Vol. 18 (1) , 9
Wnt3a promotes in situ dentin formation through NKD1-MSX1 axis-mediated odontogenic differentiation of dental pulp stem cells
The functional regeneration of the dentin-pulp complex is pivotal for tooth preservation, yet the molecular mechanisms governing odontoblast differentiation remain poorly understood. In the current study, we revealed a distinct NKD1 + subpopulation exhibiting secretory odontoblast characteristics, which was specifically induced in dental pulp stem cells (DPSCs) by Wnt3a, but not by Wnt5a or Wnt10a through single-cell transcriptomic profiling. We then found that the NKD1 + subpopulation was functional conservation, which were consistently identified in the odontoblast layers of developing tooth germs in both murine and miniature pig models, as well as within the apical open area in human molars. This conserved spatial distribution and co-localization with DSPP strongly indicates that NKD1 + cells were active dentin-secreting odontoblasts. Analysis of gene regulatory networks using SCENIC identified MSX1 as a key transcription factor regulating the specification of NKD1 + lineage. Mechanistically, Wnt3a orchestrates a tripartite cascade: upregulating NKD1/MSX1 expression, triggering NKD1 membrane detachment, and facilitating direct NKD1-MSX1 interaction to promote MSX1 nuclear translocation. CUT&Tag analysis demonstrated MSX1 occupancy at promoters of odontogenic regulators, establishing its necessity for odontogenic gene activation. Murine pulp exposure models validated that Wnt3a-activated NKD1-MSX1 signaling significantly enhances reparative dentin formation. This study delineates an evolutionarily conserved Wnt3a-NKD1-MSX1 axis that resolves stem cell heterogeneity into functional odontoblast commitment, providing both mechanistic insights into dentin-pulp regeneration and a foundation for targeted regenerative therapies.
- 13 January 2026
- Published by Springer Nature in International Journal of Oral Science
- Vol. 18 (1) , 9
Open AccessWnt3a promotes in situ dentin formation through NKD1-MSX1 axis-mediated odontogenic differentiation of dental pulp stem cells
The functional regeneration of the dentin-pulp complex is pivotal for tooth preservation, yet the molecular mechanisms governing odontoblast differentiation remain poorly understood. In the current study, we revealed a distinct NKD1 + subpopulation exhibiting secretory odontoblast characteristics, which was specifically induced in dental pulp stem cells (DPSCs) by Wnt3a, but not by Wnt5a or Wnt10a through single-cell transcriptomic profiling. We then found that the NKD1 + subpopulation was functional conservation, which were consistently identified in the odontoblast layers of developing tooth germs in both murine and miniature pig models, as well as within the apical open area in human molars. This conserved spatial distribution and co-localization with DSPP strongly indicates that NKD1 + cells were active dentin-secreting odontoblasts. Analysis of gene regulatory networks using SCENIC identified MSX1 as a key transcription factor regulating the specification of NKD1 + lineage. Mechanistically, Wnt3a orchestrates a tripartite cascade: upregulating NKD1/MSX1 expression, triggering NKD1 membrane detachment, and facilitating direct NKD1-MSX1 interaction to promote MSX1 nuclear translocation. CUT&Tag analysis demonstrated MSX1 occupancy at promoters of odontogenic regulators, establishing its necessity for odontogenic gene activation. Murine pulp exposure models validated that Wnt3a-activated NKD1-MSX1 signaling significantly enhances reparative dentin formation. This study delineates an evolutionarily conserved Wnt3a-NKD1-MSX1 axis that resolves stem cell heterogeneity into functional odontoblast commitment, providing both mechanistic insights into dentin-pulp regeneration and a foundation for targeted regenerative therapies.
- Open Access
- 17 November 2025
- Published by Elsevier in International Dental Journal
- Vol. 76 (1) , 104009
Mendelian Randomization and ScTranscriptomics Reveal a Lipid Low Malignant Cells Driving Immunosuppression and Matrix Remodeling in Oral squamous cell carcinoma
- 17 November 2025
- Published by Elsevier in International Dental Journal
- Vol. 76 (1) , 104009
Open AccessMendelian Randomization and ScTranscriptomics Reveal a Lipid Low Malignant Cells Driving Immunosuppression and Matrix Remodeling in Oral squamous cell carcinoma
- Open Access
- 1 September 2025
- Published by Tsinghua University Press in Oral Science and Homeostatic Medicine
- Vol. 1 (2)
Dental implant surface modification for promoting peri-implant osseointegration in osteoporosis
Osteoporosis (OP) is a metabolic disease characterized by reduced bone mass, decreased bone mineral density, and increased bone fragility. This not only makes patients prone to fractures but also renders the bone tissues in the oral cavity vulnerable to damage, leading to premature loosening and loss of teeth. Implant prosthodontics is currently the best approach for managing partial and complete edentulism. When implants are placed in the oral cavity of OP patients, there is a delay in osseointegration and insufficient primary stability of dental implants, which affects the success rate of implantation. Ensuring their quick and firm integration with the bone tissue in the body of OP patients is a pressing issue that needs to be addressed in the field of oral implant prosthetics. This paper reviews commonly used methods of implant surface modification, such as physical, chemical, and biological modifications, and discusses the advantages of these technologies and the mechanisms of anti-OP effects, aiming at improving osseointegration of implants in OP patients, shortening the healing period, and enhancing the success rate of implantation. This will be significant for the research and development of new implants and for expanding the clinical indications of implant prosthodontics.
- 1 September 2025
- Published by Tsinghua University Press in Oral Science and Homeostatic Medicine
- Vol. 1 (2)
Open AccessDental implant surface modification for promoting peri-implant osseointegration in osteoporosis
Osteoporosis (OP) is a metabolic disease characterized by reduced bone mass, decreased bone mineral density, and increased bone fragility. This not only makes patients prone to fractures but also renders the bone tissues in the oral cavity vulnerable to damage, leading to premature loosening and loss of teeth. Implant prosthodontics is currently the best approach for managing partial and complete edentulism. When implants are placed in the oral cavity of OP patients, there is a delay in osseointegration and insufficient primary stability of dental implants, which affects the success rate of implantation. Ensuring their quick and firm integration with the bone tissue in the body of OP patients is a pressing issue that needs to be addressed in the field of oral implant prosthetics. This paper reviews commonly used methods of implant surface modification, such as physical, chemical, and biological modifications, and discusses the advantages of these technologies and the mechanisms of anti-OP effects, aiming at improving osseointegration of implants in OP patients, shortening the healing period, and enhancing the success rate of implantation. This will be significant for the research and development of new implants and for expanding the clinical indications of implant prosthodontics.
- Open Access
- 1 September 2025
- Published by Tsinghua University Press in Oral Science and Homeostatic Medicine
- Vol. 1 (2)
MiR-145 affects cell cycles by inhibiting cyclin A2 and cyclin dependent kinase 6 in oral squamous cell carcinoma, a progression and prognostic biomarker
Identifying novel prognostic markers is crucial for predicting clinical outcomes and guiding targeted therapies. This study explores the biomarker potential of specific miRNAs, particularly miR-145 and miR-21, in the prognosis of oral squamous cell carcinoma (OSCC) and their associated mechanisms. mRNA and miRNA expression profiles were analyzed in OSCC patients. Bioinformatic analysis identified miR-145 and miR-21 as key markers. Clinical data from 87 patients showed that high miR-145 and low miR-21 expression correlated with a 91.6% 5-year survival rate. Functional studies showed that miR-145 induced G0/G1 phase arrest and shortened the S phase in OSCC cells. Overexpressing miR-145 or knocking down cyclin A2 (CCNA2) or cyclin-dependent kinase 6 (CDK6) inhibited OSCC cell proliferation. Dual-luciferase assays confirmed that miR-145 directly targets the 3′-UTRs of CCNA2 and CDK6, reducing their expression. MiR-145, particularly when combined with miR-21, is a promising OSCC prognostic biomarker. It exerts its effects by modulating the cell cycle via CCNA2 and CDK6 suppression.
- 1 September 2025
- Published by Tsinghua University Press in Oral Science and Homeostatic Medicine
- Vol. 1 (2)
Open AccessMiR-145 affects cell cycles by inhibiting cyclin A2 and cyclin dependent kinase 6 in oral squamous cell carcinoma, a progression and prognostic biomarker
Identifying novel prognostic markers is crucial for predicting clinical outcomes and guiding targeted therapies. This study explores the biomarker potential of specific miRNAs, particularly miR-145 and miR-21, in the prognosis of oral squamous cell carcinoma (OSCC) and their associated mechanisms. mRNA and miRNA expression profiles were analyzed in OSCC patients. Bioinformatic analysis identified miR-145 and miR-21 as key markers. Clinical data from 87 patients showed that high miR-145 and low miR-21 expression correlated with a 91.6% 5-year survival rate. Functional studies showed that miR-145 induced G0/G1 phase arrest and shortened the S phase in OSCC cells. Overexpressing miR-145 or knocking down cyclin A2 (CCNA2) or cyclin-dependent kinase 6 (CDK6) inhibited OSCC cell proliferation. Dual-luciferase assays confirmed that miR-145 directly targets the 3′-UTRs of CCNA2 and CDK6, reducing their expression. MiR-145, particularly when combined with miR-21, is a promising OSCC prognostic biomarker. It exerts its effects by modulating the cell cycle via CCNA2 and CDK6 suppression.
- Open Access
- 24 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-16
Induction and characterization of oral submucous fibrosis model with different pathological stages in rats and mice
Oral submucous fibrosis (OSF) is a chronic and progressive fibrosis disease. Although its pathological stages are well characterized in clinical settings, corresponding animal models remain lacking, which has significantly hindered in-depth mechanistic studies and the development of targeted interventions. Herein, we developed new methods in creating OSF models in rats and mice by different injection frequency of bleomycin (BLM) to simulate early and middle stages of fibrosis. The results showed both low-frequency (once a week) and high-frequency (twice a week) of injection can cause significant fibrosis characteristics, including mucosal pallor, limitation of mouth opening, collagen deposition and inflammatory response. Histological and molecular analyses confirm the stage-dependent pathological changes. Furthermore, to validate the pathological relevance of the model, human oral mucosal tissues from OSF patients and healthy individuals were also analyzed. The result exhibits that, compared with low-frequency injections, high-frequency injections of BLM can lead to more serious fibrosis and inflammatory responses in rats and mice, which are corresponding with the early and middle characteristics of human OSF. This work developed stable and repeatable OSF models of rats and mice in different pathological stages, which offer valuable tools for mechanistic studies of OSF and further precise stage-specific therapies.
- 24 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-16
Open AccessInduction and characterization of oral submucous fibrosis model with different pathological stages in rats and mice
Oral submucous fibrosis (OSF) is a chronic and progressive fibrosis disease. Although its pathological stages are well characterized in clinical settings, corresponding animal models remain lacking, which has significantly hindered in-depth mechanistic studies and the development of targeted interventions. Herein, we developed new methods in creating OSF models in rats and mice by different injection frequency of bleomycin (BLM) to simulate early and middle stages of fibrosis. The results showed both low-frequency (once a week) and high-frequency (twice a week) of injection can cause significant fibrosis characteristics, including mucosal pallor, limitation of mouth opening, collagen deposition and inflammatory response. Histological and molecular analyses confirm the stage-dependent pathological changes. Furthermore, to validate the pathological relevance of the model, human oral mucosal tissues from OSF patients and healthy individuals were also analyzed. The result exhibits that, compared with low-frequency injections, high-frequency injections of BLM can lead to more serious fibrosis and inflammatory responses in rats and mice, which are corresponding with the early and middle characteristics of human OSF. This work developed stable and repeatable OSF models of rats and mice in different pathological stages, which offer valuable tools for mechanistic studies of OSF and further precise stage-specific therapies.
- Open Access
- 30 July 2025
- Published by Wiley in Smart Medicine
- Vol. 4 (3)
Mechanistic Insights Into Overloading‐Induced Terminal Differentiation of TMJ Condylar Cartilage at the Single Cell Level
The incidence of temporomandibular joint (TMJ) degeneration has been steadily increasing, with overloading identified as a major risk factor. This condition often leads to condylar cartilage degeneration, significantly affecting patients' quality of life; however, the molecular mechanisms underlying this process remain poorly understood, and effective treatments are still lacking. We utilized single‐nucleus RNA sequencing to analyze the condylar cartilage in an overloading mouse model. This approach enabled the identification of 11 distinct cell types within the condylar chondrocytes. Through the application of pseudotime trajectory Analysis and cellchat analyses, we identified the key gene Acvr1b and its associated signaling pathway, which are crucial for regulating the terminal differentiation of condylar chondrocytes. This study utilized single‐nucleus RNA sequencing and in vitro validation to investigate the role of Acvr1b in TMJ cartilage degeneration under overloading stress. Our findings reveal key pathways involved in chondrocyte differentiation, providing a theoretical basis for the development of targeted therapeutic interventions.
- 30 July 2025
- Published by Wiley in Smart Medicine
- Vol. 4 (3)
Open AccessMechanistic Insights Into Overloading‐Induced Terminal Differentiation of TMJ Condylar Cartilage at the Single Cell Level
The incidence of temporomandibular joint (TMJ) degeneration has been steadily increasing, with overloading identified as a major risk factor. This condition often leads to condylar cartilage degeneration, significantly affecting patients' quality of life; however, the molecular mechanisms underlying this process remain poorly understood, and effective treatments are still lacking. We utilized single‐nucleus RNA sequencing to analyze the condylar cartilage in an overloading mouse model. This approach enabled the identification of 11 distinct cell types within the condylar chondrocytes. Through the application of pseudotime trajectory Analysis and cellchat analyses, we identified the key gene Acvr1b and its associated signaling pathway, which are crucial for regulating the terminal differentiation of condylar chondrocytes. This study utilized single‐nucleus RNA sequencing and in vitro validation to investigate the role of Acvr1b in TMJ cartilage degeneration under overloading stress. Our findings reveal key pathways involved in chondrocyte differentiation, providing a theoretical basis for the development of targeted therapeutic interventions.
- Open Access
- 14 July 2025
- Published by Wiley
Profiling Fibrosis through Single-Cell and Spatial Transcriptomics Analysis: cell identity and tissue architecture
Fibrosis, characterized by the excessive accumulation of structural and matricellular proteins in the extracellular matrix (ECM), contributes to tissue dysfunction in various chronic diseases. A central therapeutic challenge lies in identifying and targeting specific molecular drivers of fibrosis while preserving essential wound-healing functions, thereby halting or reversing disease progression. Recent single-cell transcriptomic analyses of human fibrotic tissues have revealed distinct populations of mesenchymal cells that orchestrate pathological ECM production. These studies identified a distinct pattern of interaction between these mesenchymal cells and immune cells within the fibrotic environment, playing a key role in tissue remodeling. Here, we review recent advances in understanding the fibrotic microenvironment across organs, focusing on fibroblast activation in fibrosis, and elucidating the conserved mechanisms of fibrosis across organs through the study of mesenchymal cells, immune cells, and epithelial cells.
- 14 July 2025
- Published by Wiley
Open AccessProfiling Fibrosis through Single-Cell and Spatial Transcriptomics Analysis: cell identity and tissue architecture
Fibrosis, characterized by the excessive accumulation of structural and matricellular proteins in the extracellular matrix (ECM), contributes to tissue dysfunction in various chronic diseases. A central therapeutic challenge lies in identifying and targeting specific molecular drivers of fibrosis while preserving essential wound-healing functions, thereby halting or reversing disease progression. Recent single-cell transcriptomic analyses of human fibrotic tissues have revealed distinct populations of mesenchymal cells that orchestrate pathological ECM production. These studies identified a distinct pattern of interaction between these mesenchymal cells and immune cells within the fibrotic environment, playing a key role in tissue remodeling. Here, we review recent advances in understanding the fibrotic microenvironment across organs, focusing on fibroblast activation in fibrosis, and elucidating the conserved mechanisms of fibrosis across organs through the study of mesenchymal cells, immune cells, and epithelial cells.